These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 532633)

  • 1. [Investigations on the influence of L-DOPA on experimental epilepsy (author's transl)].
    Pei YQ; Tang J; Cui JR; Yue W
    Yao Xue Xue Bao; 1979 Jul; 14(7):389-96. PubMed ID: 532633
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of DOPA accumulation by rat brain at critical L-DOPA circulating concentrations.
    Horst WD; Bautz G; Renyi E; Spirt N
    Adv Neurol; 1974; 5():369-73. PubMed ID: 4440584
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antagonism between L-DOPA and apomorphine in their effects on rat behavior].
    Allikmets LKh; Zharkovskiĭ Am; Vasar EE
    Biull Eksp Biol Med; 1977 Jul; 84(7):51-3. PubMed ID: 560890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of pyridoxine administration in L-dopa therapy of Parkinsonism (author's transl)].
    Namba S; Ishimitsu H; Nakasone S
    No To Shinkei; 1980 Oct; 32(10):991-1000. PubMed ID: 6159908
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of levodopa on brain levels of noradrenaline, dopamine and homovanillic acid in experimental portosystemic encephalopathy].
    Arias J; Alsasua A; Estebánez E; López-Sánchez ML; Arias JI; Durán M; García de Jalón PD; Durán Sacristán H
    Rev Clin Esp; 1982 Sep; 166(5):221-4. PubMed ID: 7146544
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of post-etorphine catalepsy. Modyfying effect of amphetamine, apomorphine and dihydroxy-phenylalanine (L-dopa) on etorphine-induced concentrations of dopamine and noradrenaline in the rat central nervous system.
    Kania BF
    Acta Physiol Pol; 1979; 30(2):279-87. PubMed ID: 572616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-dopa on self-stimulation and brain biogenic amines in rats.
    Nimitkitpaisan Y; Bose S; Kumar R; Pradhan SN
    Neuropharmacology; 1977 Oct; 16(10):657-61. PubMed ID: 593529
    [No Abstract]   [Full Text] [Related]  

  • 8. [The brain catecholamine systems in the regulation of dominance].
    Serova LI; Naumenko EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aminergic neurones (author's transl)].
    Tanaka C; Inagaki C
    Tanpakushitsu Kakusan Koso; 1977; 22(6):524-9. PubMed ID: 412229
    [No Abstract]   [Full Text] [Related]  

  • 10. [Increase of cerebral dopamine levels by alpha-chymotrypsin in rats pretreated with oxypertine and L-dopa].
    Van den Driessche J; Le Clec'h G; Quiniou P; Linée P; Lacroix P; Patay M; Delamaire J
    C R Seances Soc Biol Fil; 1974; 168(10-11-12):1393-400. PubMed ID: 4157065
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of PCB on the treated brain mercury contents and monoamine levels in rats (author's transl)].
    Yamada K; Hidaka T; Suenaga N; Ueda J; Fukuda T
    Fukuoka Igaku Zasshi; 1977 Jul; 68(7):349-53. PubMed ID: 410721
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of hypoxia-induced disturbances by previous treatment with benserazide and L-dopa in rats.
    Boismare F; le Poncin M; Belliard JP; Hacpille L
    Experientia; 1975 Oct; 31(10):1190-1. PubMed ID: 1204736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered behavioural and neurochemical profile of L-DOPA following deuterium substitutions in the molecule.
    Malmlöf T; Svensson TH; Schilström B
    Exp Neurol; 2008 Aug; 212(2):538-42. PubMed ID: 18561915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age and changes in the levels of biogenic amines in the brains of rats].
    Anisimov VN; Pozdeev VK; Dmitrievskaia AIu; Gracheva GM; Il'in AP
    Fiziol Zh SSSR Im I M Sechenova; 1977 Mar; 63(3):353-8. PubMed ID: 863030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [L-dopa treatment in parkinsonism. Biochemical basis (author's transl)].
    Bieniowa A; Kolasa M; Reichowa J
    Przegl Lek; 1976; 33(4):463-7. PubMed ID: 1273343
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain catecholamine concentration during the first week of development in rats.
    Phelps CP; Korányi L; Tamásy V
    Dev Neurosci; 1982; 5(5-6):503-7. PubMed ID: 7160315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of catecholaminergic mechanisms of the brain in fixation of temporary connections].
    Orlova NV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1978; 28(3):538-41. PubMed ID: 676501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of brain norepinephrine in audiogenic seizure in the rat.
    Jobe PC; Picchioni AL; Chin L
    J Pharmacol Exp Ther; 1973 Jan; 184(1):1-10. PubMed ID: 4686009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.